Hill-Rom Holdings Total Assets 2006-2019 | HRC

Hill-Rom Holdings total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Hill-Rom Holdings total assets for the quarter ending December 31, 2019 were $4.519B, a 3.87% increase year-over-year.
  • Hill-Rom Holdings total assets for 2019 were $4.919B, a 12.82% increase from 2018.
  • Hill-Rom Holdings total assets for 2018 were $4.36B, a 3.73% decline from 2017.
  • Hill-Rom Holdings total assets for 2017 were $4.529B, a 6.25% increase from 2016.
Hill-Rom Holdings Annual Total Assets
(Millions of US $)
2019 $4,919
2018 $4,360
2017 $4,529
2016 $4,262
2015 $4,458
2014 $1,751
2013 $1,587
2012 $1,628
2011 $1,299
2010 $1,246
2009 $1,233
2008 $1,690
2007 $2,117
2006 $1,952
2005 $2,229
Hill-Rom Holdings Quarterly Total Assets
(Millions of US $)
2019-12-31 $4,519
2019-09-30 $4,919
2019-06-30 $4,575
2019-03-31 $4,368
2018-12-31 $4,350
2018-09-30 $4,360
2018-06-30 $4,465
2018-03-31 $4,505
2017-12-31 $4,461
2017-09-30 $4,529
2017-06-30 $4,484
2017-03-31 $4,473
2016-12-31 $4,144
2016-09-30 $4,262
2016-06-30 $4,237
2016-03-31 $4,243
2015-12-31 $4,272
2015-09-30 $4,458
2015-06-30 $1,758
2015-03-31 $1,706
2014-12-31 $1,736
2014-09-30 $1,751
2014-06-30 $1,487
2014-03-31 $1,520
2013-12-31 $1,527
2013-09-30 $1,587
2013-06-30 $1,553
2013-03-31 $1,572
2012-12-31 $1,615
2012-09-30 $1,628
2012-06-30 $1,300
2012-03-31 $1,292
2011-12-31 $1,223
2011-09-30 $1,299
2011-06-30 $1,302
2011-03-31 $1,281
2010-12-31 $1,224
2010-09-30 $1,246
2010-06-30 $1,233
2010-03-31 $1,220
2009-12-31 $1,197
2009-09-30 $1,233
2009-06-30 $1,169
2009-03-31 $1,172
2008-12-31 $1,625
2008-09-30 $1,690
2008-06-30 $1,600
2008-03-31 $1,637
2007-12-31 $2,165
2007-09-30 $2,117
2007-06-30 $2,068
2007-03-31 $2,035
2006-12-31 $2,003
2006-09-30 $1,952
2006-06-30 $2,190
2006-03-31 $2,128
2005-12-31 $2,264
2005-09-30 $2,229
2005-06-30 $1,992
2005-03-31 $2,055
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.224B $2.907B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.087B 24.52
Medtronic (MDT) Ireland $115.455B 15.52
Stryker (SYK) United States $56.067B 18.11
Boston Scientific (BSX) United States $43.352B 19.53
Baxter (BAX) United States $41.707B 25.46
Coloplast (CLPBY) Denmark $31.190B 48.13
Lonza Group Ag (LZAGY) Switzerland $30.205B 0.00
Terumo (TRUMY) Japan $25.702B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $22.826B 0.00
ResMed (RMD) United States $21.711B 37.72
Zimmer Biomet Holdings (ZBH) United States $19.136B 11.78
Smith & Nephew SNATS (SNN) United Kingdom $14.916B 0.00
Sunny Optical Technology (SNPTF) China $14.456B 0.00
Bio-Rad Laboratories (BIO) United States $10.795B 50.45
Insulet (PODD) United States $10.501B 642.46
William Demant Holdings (WILYY) Denmark $7.898B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Perrigo (PRGO) Ireland $5.826B 10.62
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Haemonetics (HAE) United States $5.020B 30.90
Canopy Growth (CGC) Canada $4.821B 0.00
ICU Medical (ICUI) United States $4.255B 27.79
Quidel (QDEL) United States $3.982B 34.95
Neogen (NEOG) United States $3.497B 59.23
GW Pharmaceuticals (GWPH) United Kingdom $2.614B 0.00
Agios Pharmaceuticals (AGIO) United States $2.551B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.392B 0.00
NuVasive (NUVA) United States $2.346B 18.14
Envista Holdings (NVST) United States $2.262B 0.00
National Vision Holdings (EYE) United States $1.325B 22.32
AtriCure (ATRC) United States $1.321B 0.00
Cardiovascular Systems (CSII) United States $1.294B 0.00
TG Therapeutics (TGTX) United States $1.032B 0.00
Aurora Cannabis (ACB) Canada $1.014B 0.00
Phibro Animal Health (PAHC) United States $0.998B 19.73
NanoString Technologies (NSTG) United States $0.846B 0.00
VAREX IMAGING (VREX) United States $0.829B 17.23
DFB Healthcare Acquisitions (AHCO) United States $0.776B 139.62
Aphria (APHA) $0.772B 0.00
Cerus (CERS) United States $0.735B 0.00
Omeros (OMER) United States $0.662B 0.00
InMode (INMD) Israel $0.659B 0.00
OraSure Technologies (OSUR) United States $0.650B 80.61
Eagle Pharmaceuticals (EGRX) United States $0.617B 36.70
PetIQ (PETQ) United States $0.574B 15.61
Quanterix (QTRX) United States $0.566B 0.00
Owens & Minor (OMI) United States $0.472B 12.90
LeMaitre Vascular (LMAT) United States $0.466B 26.26
Surmodics (SRDX) United States $0.461B 52.98
Lantheus Holdings (LNTH) United States $0.443B 9.96
Vapotherm (VAPO) United States $0.381B 0.00
Meridian Bioscience (VIVO) United States $0.370B 14.91
Zynex (ZYXI) United States $0.349B 38.04
Utah Medical Products (UTMD) United States $0.328B 23.44
Organigram Holdings (OGI) Canada $0.315B 0.00
Repro-Med Systems (KRMD) United States $0.279B 175.75
Cytosorbents (CTSO) United States $0.268B 0.00
MacroGenics (MGNX) United States $0.266B 0.00
HEXO (HEXO) $0.205B 0.00
Female Health (VERU) United States $0.201B 0.00
BioLife Solutions (BLFS) United States $0.193B 118.25
InfuSystems Holdings (INFU) United States $0.178B 148.33
Viemed Healthcare (VMD) United States $0.177B 20.00
Exagen (XGN) United States $0.161B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Rockwell Medical (RMTI) United States $0.131B 0.00
Bovie Medical (APYX) United States $0.128B 0.00
Evolus (EOLS) United States $0.127B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Fonar (FONR) United States $0.096B 7.01
Chimerix (CMRX) United States $0.085B 0.00
Brainsway (BWAY) Israel $0.081B 0.00
MTech Acquisition (KERN) United States $0.070B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.064B 0.00
United-Guardian (UG) United States $0.059B 12.45
Nephros (NEPH) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.044B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.030B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00